Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Oncologie closes $80mm Series B round

Executive Summary

Oncologie Inc. (biologics and small-molecule therapies for cancer) raised $80mm through its Series B round from Nan Fung Life Sciences and Pivotal BioVentures China (co-leads), along with a syndicate of new investors including Panacea Venture Healthcare and Korea Investment Partners. Proceeds will support continued development of the company's three clinical projects for solid tumors (bavituximab, lefitolimod, and varisacumab), and will also go towards in-licensings and development of a biomarker platform.
Deal Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies